Skip to main content
Top
Published in: European Radiology 4/2018

Open Access 01-04-2018 | Gastrointestinal

Secretin-stimulated ultrasound estimation of pancreatic secretion in cystic fibrosis validated by magnetic resonance imaging

Authors: Trond Engjom, Erling Tjora, Gaute Wathle, Friedemann Erchinger, Birger N. Lærum, Odd H. Gilja, Ingfrid Salvesen Haldorsen, Georg Dimcevski

Published in: European Radiology | Issue 4/2018

Login to get access

Abstract

Objectives

Secretin-stimulated magnetic resonance imaging (s-MRI) is the best validated radiological modality assessing pancreatic secretion. The purpose of this study was to compare volume output measures from secretin-stimulated transabdominal ultrasonography (s-US) to s-MRI for the diagnosis of exocrine pancreatic failure in cystic fibrosis (CF).

Methods

We performed transabdominal ultrasonography and MRI before and at timed intervals during 15 minutes after secretin stimulation in 21 CF patients and 13 healthy controls. To clearly identify the subjects with reduced exocrine pancreatic function, we classified CF patients as pancreas-sufficient or -insufficient by secretin-stimulated endoscopic short test and faecal elastase.

Results

Pancreas-insufficient CF patients had reduced pancreatic secretions compared to pancreas-sufficient subjects based on both imaging modalities (p < 0.001). Volume output estimates assessed by s-US correlated to that of s-MRI (r = 0.56–0.62; p < 0.001). Both s-US (AUC: 0.88) and s-MRI (AUC: 0.99) demonstrated good diagnostic accuracy for exocrine pancreatic failure.

Conclusions

Pancreatic volume-output estimated by s-US corresponds well to exocrine pancreatic function in CF patients and yields comparable results to that of s-MRI. s-US provides a simple and feasible tool in the assessment of pancreatic secretion.

Key points

• Cystic fibrosis patients with affected pancreas have reduced pancreatic secretions.
Secretin-stimulated sonography is a simple and feasible method to assess pancreatic output.
Secretin-simulated MRI is a more precise method to assess pancreatic secretions.
The sonographic and MRI methods yielded comparable pancreatic secretory output estimates.
Literature
2.
go back to reference Durie PR, Forstner GG (1989) Pathophysiology of the exocrine pancreas in cystic fibrosis. JR Soc Med 82:2–10 Durie PR, Forstner GG (1989) Pathophysiology of the exocrine pancreas in cystic fibrosis. JR Soc Med 82:2–10
3.
go back to reference Kopelman H, Corey M, Gaskin K, Durie P, Weizman Z, Forstner G (1988) Impaired chloride secretion, as well as bicarbonate secretion, underlies the fluid secretory defect in the cystic fibrosis pancreas. Gastroenterology 95:349–355CrossRefPubMed Kopelman H, Corey M, Gaskin K, Durie P, Weizman Z, Forstner G (1988) Impaired chloride secretion, as well as bicarbonate secretion, underlies the fluid secretory defect in the cystic fibrosis pancreas. Gastroenterology 95:349–355CrossRefPubMed
4.
go back to reference Kopito LE, Shwachman H (1976) The pancreas in cystic fibrosis: chemical composition and comparative morphology. Pediatr Res 10:742–749PubMed Kopito LE, Shwachman H (1976) The pancreas in cystic fibrosis: chemical composition and comparative morphology. Pediatr Res 10:742–749PubMed
5.
go back to reference Kopelman H, Durie P, Gaskin K, Weizman Z, Forstner G (1985) Pancreatic fluid secretion and protein hyperconcentration in cystic fibrosis. N Engl J Med 312:329–334CrossRefPubMed Kopelman H, Durie P, Gaskin K, Weizman Z, Forstner G (1985) Pancreatic fluid secretion and protein hyperconcentration in cystic fibrosis. N Engl J Med 312:329–334CrossRefPubMed
7.
go back to reference Ramsey BW, Davies J, McElvaney NG et al (2011) A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 365:1663–1672CrossRefPubMedPubMedCentral Ramsey BW, Davies J, McElvaney NG et al (2011) A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 365:1663–1672CrossRefPubMedPubMedCentral
8.
go back to reference Schibli S, Corey M, Gaskin KJ, Ellis L, Durie PR (2006) Towards the ideal quantitative pancreatic function test: analysis of test variables that influence validity. Clin Gastroenterol Hepatol 4:90–97CrossRefPubMed Schibli S, Corey M, Gaskin KJ, Ellis L, Durie PR (2006) Towards the ideal quantitative pancreatic function test: analysis of test variables that influence validity. Clin Gastroenterol Hepatol 4:90–97CrossRefPubMed
9.
go back to reference Engjom T, Erchinger F, Laerum BN et al (2015) Diagnostic Accuracy of a Short Endoscopic Secretin Test in Patients With Cystic Fibrosis. Pancreas 44:1266–1272CrossRefPubMedPubMedCentral Engjom T, Erchinger F, Laerum BN et al (2015) Diagnostic Accuracy of a Short Endoscopic Secretin Test in Patients With Cystic Fibrosis. Pancreas 44:1266–1272CrossRefPubMedPubMedCentral
10.
go back to reference Madzak A, Olesen SS, Wathle GK, Haldorsen IS, Drewes AM, Frokjaer JB (2016) Secretin-Stimulated Magnetic Resonance Imaging Assessment of the Benign Pancreatic Disorders: Systematic Review and Proposal for a Standardized Protocol. Pancreas 45:1092–1103CrossRefPubMed Madzak A, Olesen SS, Wathle GK, Haldorsen IS, Drewes AM, Frokjaer JB (2016) Secretin-Stimulated Magnetic Resonance Imaging Assessment of the Benign Pancreatic Disorders: Systematic Review and Proposal for a Standardized Protocol. Pancreas 45:1092–1103CrossRefPubMed
11.
go back to reference Madzak A, Engjom T, Wathle GK et al (2017) Secretin-stimulated MRI assessment of exocrine pancreatic function in patients with cystic fibrosis and healthy controls. Abdom Radiol 42:890–899CrossRef Madzak A, Engjom T, Wathle GK et al (2017) Secretin-stimulated MRI assessment of exocrine pancreatic function in patients with cystic fibrosis and healthy controls. Abdom Radiol 42:890–899CrossRef
12.
go back to reference Yasokawa K, Ito K, Tamada T et al (2016) Postprandial changes in secretory flow of pancreatic juice in the main pancreatic duct: evaluation with cine-dynamic MRCP with a spatially selective inversion-recovery (IR) pulse. Eur Radiol 26:4339–4344CrossRefPubMed Yasokawa K, Ito K, Tamada T et al (2016) Postprandial changes in secretory flow of pancreatic juice in the main pancreatic duct: evaluation with cine-dynamic MRCP with a spatially selective inversion-recovery (IR) pulse. Eur Radiol 26:4339–4344CrossRefPubMed
13.
go back to reference Jonczyk-Potoczna K, Nowak JK, Madry E et al (2016) Secretin-enhanced Magnetic Resonance Cholangio-pancreatography in Pancreatic Insufficient and Pancreatic Sufficient Cystic Fibrosis Patients. J Gastrointestin Liver Dis 25:57–62PubMed Jonczyk-Potoczna K, Nowak JK, Madry E et al (2016) Secretin-enhanced Magnetic Resonance Cholangio-pancreatography in Pancreatic Insufficient and Pancreatic Sufficient Cystic Fibrosis Patients. J Gastrointestin Liver Dis 25:57–62PubMed
15.
go back to reference Dimcevski G, Erchinger FG, Havre R, Gilja OH (2013) Ultrasonography in diagnosing chronic pancreatitis: new aspects. World J Gastroenterol 19:7247–7257CrossRefPubMedPubMedCentral Dimcevski G, Erchinger FG, Havre R, Gilja OH (2013) Ultrasonography in diagnosing chronic pancreatitis: new aspects. World J Gastroenterol 19:7247–7257CrossRefPubMedPubMedCentral
17.
go back to reference Engjom T, Erchinger F, Tjora E, Laerum BN, Georg D, Gilja OH (2015) Diagnostic accuracy of secretin-stimulated ultrasonography of the pancreas assessing exocrine pancreatic failure in cystic fibrosis and chronic pancreatitis. Scand J Gastroenterol. 50:601–610CrossRefPubMed Engjom T, Erchinger F, Tjora E, Laerum BN, Georg D, Gilja OH (2015) Diagnostic accuracy of secretin-stimulated ultrasonography of the pancreas assessing exocrine pancreatic failure in cystic fibrosis and chronic pancreatitis. Scand J Gastroenterol. 50:601–610CrossRefPubMed
18.
go back to reference Farrell PM, Rosenstein BJ, White TB et al (2008) Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 153:S4–S14CrossRefPubMedPubMedCentral Farrell PM, Rosenstein BJ, White TB et al (2008) Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 153:S4–S14CrossRefPubMedPubMedCentral
19.
go back to reference Borowitz D, Baker SS, Duffy L et al (2004) Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosis. J Pediatr 145:322–326CrossRefPubMed Borowitz D, Baker SS, Duffy L et al (2004) Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosis. J Pediatr 145:322–326CrossRefPubMed
20.
go back to reference Somogyi L, Ross SO, Cintron M, Toskes PP (2003) Comparison of biologic porcine secretin, synthetic porcine secretin, and synthetic human secretin in pancreatic function testing. Pancreas 27:230–234CrossRefPubMed Somogyi L, Ross SO, Cintron M, Toskes PP (2003) Comparison of biologic porcine secretin, synthetic porcine secretin, and synthetic human secretin in pancreatic function testing. Pancreas 27:230–234CrossRefPubMed
21.
go back to reference Wathle GK, Tjora E, Ersland L et al (2014) Assessment of exocrine pancreatic function by secretin-stimulated magnetic resonance cholangiopancreaticography and diffusion-weighted imaging in healthy controls. J Magn Reson Imaging 39:448–454CrossRefPubMed Wathle GK, Tjora E, Ersland L et al (2014) Assessment of exocrine pancreatic function by secretin-stimulated magnetic resonance cholangiopancreaticography and diffusion-weighted imaging in healthy controls. J Magn Reson Imaging 39:448–454CrossRefPubMed
22.
go back to reference Erchinger F, Engjom T, Tjora E et al (2013) Quantification of pancreatic function using a clinically feasible short endoscopic secretin test. Pancreas 42:1101–1106CrossRefPubMed Erchinger F, Engjom T, Tjora E et al (2013) Quantification of pancreatic function using a clinically feasible short endoscopic secretin test. Pancreas 42:1101–1106CrossRefPubMed
24.
go back to reference Tjora E, Wathle G, Erchinger F et al (2013) Exocrine pancreatic function in hepatocyte nuclear factor 1beta-maturity-onset diabetes of the young (HNF1B-MODY) is only moderately reduced: compensatory hypersecretion from a hypoplastic pancreas. Diabet Med 30:946–955CrossRefPubMed Tjora E, Wathle G, Erchinger F et al (2013) Exocrine pancreatic function in hepatocyte nuclear factor 1beta-maturity-onset diabetes of the young (HNF1B-MODY) is only moderately reduced: compensatory hypersecretion from a hypoplastic pancreas. Diabet Med 30:946–955CrossRefPubMed
25.
go back to reference O'Sullivan BP, Baker D, Leung KG, Reed G, Baker SS, Borowitz D (2013) Evolution of Pancreatic Function during the First Year in Infants with Cystic Fibrosis. J Pediatr 162:808–812CrossRefPubMed O'Sullivan BP, Baker D, Leung KG, Reed G, Baker SS, Borowitz D (2013) Evolution of Pancreatic Function during the First Year in Infants with Cystic Fibrosis. J Pediatr 162:808–812CrossRefPubMed
26.
go back to reference Couper RT, Corey M, Moore DJ, Fisher LJ, Forstner GG, Durie PR (1992) Decline of exocrine pancreatic function in cystic fibrosis patients with pancreatic sufficiency. Pediatr Res 32:179–182CrossRefPubMed Couper RT, Corey M, Moore DJ, Fisher LJ, Forstner GG, Durie PR (1992) Decline of exocrine pancreatic function in cystic fibrosis patients with pancreatic sufficiency. Pediatr Res 32:179–182CrossRefPubMed
27.
go back to reference Gullo L, Priori P, Daniele C, Ventrucci M, Gasbarrini G, Labo G (1983) Exocrine pancreatic function in the elderly. Gerontology 29:407–411CrossRefPubMed Gullo L, Priori P, Daniele C, Ventrucci M, Gasbarrini G, Labo G (1983) Exocrine pancreatic function in the elderly. Gerontology 29:407–411CrossRefPubMed
Metadata
Title
Secretin-stimulated ultrasound estimation of pancreatic secretion in cystic fibrosis validated by magnetic resonance imaging
Authors
Trond Engjom
Erling Tjora
Gaute Wathle
Friedemann Erchinger
Birger N. Lærum
Odd H. Gilja
Ingfrid Salvesen Haldorsen
Georg Dimcevski
Publication date
01-04-2018
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 4/2018
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-017-5115-2

Other articles of this Issue 4/2018

European Radiology 4/2018 Go to the issue